Home/Smart Money/Remedium Capital Partners, LLC
§ 13F · FUND PROFILE

Remedium Capital Partners, LLC.

Institutional filer · behavioral pattern: Other. Summary pending.
AUM · (13F)Positions · 6Turnover · · Q4Filed · Feb 12, 2026
CONCENTRATION
Top 10 holdings
NEW BUYS
0
+$170.2B deployed
EXITS
0
No exits
SECTOR SHIFT
No prior quarter data
3YR HIT RATE
Top-5 overlap
§ 01 · TOP HOLDINGS

The book · Q4 2025

FILED FEB 12, 2026
#TickerNameShares$ value% portΔ Q4
1SYRESpyre Therapeutics Inc1.46M$47.7B28.0%NEW
2ORKAOruka Therapeutics Inc1.55M$47.1B27.6%NEW
3APGEApogee Therapeutics Inc584K$44.0B25.9%NEW
4JBIOJade Biosciences Inc1.58M$24.3B14.3%NEW
5CBIOCrescent Biopharma Inc361K$4.3B2.5%NEW
6DMRAGalecto Inc120K$2.8B1.6%NEW
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE REMEDIUM SIGNAL

AC read

Remedium Capital Partners, LLC is classified as a Other fund.

Read the full dossier →
§ 04 · FILING HISTORY

Q-by-Q deltas

1 FILINGS
Q4 2025
Steady book
+0 buys · 0 exits · 0 changed